Search Within

Andrew Lassman

Formats
  1. Journal Article (63)
  2. Meeting Abstract (43)
  3. Book Section (5)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (51)
  2. Epidemiology and Biostatistics (29)
  3. Biostatistics Service (28)
  4. Population Sciences Research Program (26)
  5. GSK Faculty (20)
  6. Radiology, Department of (20)

More Groups

People
  1. Lauren Abrey (49)
  2. Lisa De Angelis (49)
  3. Katherine Panageas (25)
  4. Craig Nolan (19)
  5. Igor Gavrilovic (18)
  6. Adilia Hormigo (16)

More People

Years
  1. 2020 (1)
  2. 2019 (2)
  3. 2017 (1)
  4. 2015 (2)
  5. 2014 (3)
  6. 2013 (5)

More Years

Publications
  1. Neuro-Oncology (38)
  2. Journal of Clinical Oncology (21)
  3. Journal of Neuro-Oncology (14)
  4. Clinical Cancer Research (4)
  5. International Journal of Radiation Oncology, Biology, Physics (4)
  6. Neurology (3)

More Publications

Publishers
  1. Oxford University Press (38)
  2. American Society of Clinical Oncology (21)
  3. Springer (19)
  4. Elsevier Inc. (8)
  5. American Association for Cancer Research (5)
  6. Lippincott Williams & Wilkins (4)

More Publishers

Results (111)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Isolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma
    Journal Article

    Gupta, A.; Young, R. J.; Karimi, S.; Sood, S.; Zhang, Z.; Mo, Q.; Gutin, P. H.; Holodny, A. I.; Lassman, A. B.
    American Journal of Neuroradiology (2011)

    Fulltext@MSK | Save
  • International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
    Journal Article

    Lassman, A. B.; Iwamoto, F. M.; Cloughesy, T. F.; Aldape, K. D.; Rivera, A. L.; Eichler, A. F.; Louis, D. N.; Paleologos, N. A.; Fisher, B. J.; Ashby, L. S.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept
    Journal Article

    De Groot, J. F.; Piao, Y.; Tran, H.; Gilbert, M.; Wu, H. K.; Liu, J.; Bekele, B. N.; Cloughesy, T.; Mehta, M.; Robins, H. I.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Phase II study of aflibercept in recurrent malignant glioma: A North American brain tumor consortium study
    Journal Article

    De Groot, J. F.; Lamborn, K. R.; Chang, S. M.; Gilbert, M. R.; Cloughesy, T. F.; Aldape, K.; Yao, J.; Jackson, E. F.; Lieberman, F.; Robins, H. I.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical trial end points for high-grade glioma: The evolving landscape
    Journal Article

    Reardon, D. A.; Galanis, E.; DeGroot, J. F.; Cloughesy, T. F.; Wefel, J. S.; Lamborn, K. R.; Lassman, A. B.; Gilbert, M. R.; Sampson, J. H.; Wick, W.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Seizures and radionecrosis from non-small-cell lung cancer presenting as increased fluorodeoxyglucose uptake on positron emission tomography
    Journal Article

    Morris, P. G.; Gutin, P. H.; Avila, E. K.; Rosenblum, M. K.; Lassman, A. B.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Signal transduction inhibitors and antiangiogenic therapies for malignant glioma
    Journal Article

    Mellinghoff, I. K.; Lassman, A. B.; Wen, P. Y.
    Glia (2011)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)
    Meeting Abstract

    Khasraw, M.; Abrey, L. E.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Mellinghoff, I. K.; Reiner, A. S.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Hepatic enzyme-inducing antiepileptic drug use is not associated with survival in glioblastoma multiforme
    Meeting Abstract

    Barker, C. A.; Chang, M.; Lassman, A. B.; Beal, K.; Chan, T. A.
    Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional status
    Meeting Abstract

    Laufer, M.; Chan, T.; Yamada, J.; Barker, C.; Lassman, A. B.; Beal, K.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save